Margaux Hall

Partner at Gibson Dunn

Speaker

Margaux Hall is a partner in the Washington, D.C. office of Gibson Dunn and a member of the firm’s FDA and Health Care practice.

Margaux is a leading lawyer in drug pricing, coverage, reimbursement, market access, and value-based arrangements. She brings to clients a keen understanding of the transformative legal, policy, and changes affecting pricing and access to drugs, vaccines and devices, including in government enforcement and litigation matters.

Chambers and Partners has reported that Margaux’s clients regard her as “very intelligent and knowledgeable about law, industry and government enforcement. She is thoughtful about business risks and she is innovative in providing workable risk-based solutions.” One client noted, “Margaux is one of the best I’ve worked with. She is very knowledgeable and provides practical and innovative advice.”

Margaux provides sophisticated legal and strategic business counsel to pharmaceutical manufacturers, investors, and others in the healthcare and life sciences sector on regulatory, transactional, and government enforcement matters. Her expertise spans topics of pricing, coverage, and reimbursement under Medicare Advantage-Part D, Medicaid, the Federal Supply Schedule, and commercial insurance, and government price reporting laws. Margaux advises on the evolving landscape for drug development and commercialization in connection with the Inflation Reduction Act, Most Favored Nation reforms and direct-to-patient commercialization channels.